sumatriptan has been researched along with Erythremia in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Excerpt | Relevance | Reference |
---|---|---|
"Migraines affect approximately 10% of the adult population worldwide." | 2.73 | A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. ( Dubé, LM; Jackson, D; Kaldeway, P; Morris, R; O'Neill, C; Sebree, T; Siegel, SJ, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siegel, SJ | 1 |
O'Neill, C | 1 |
Dubé, LM | 1 |
Kaldeway, P | 1 |
Morris, R | 1 |
Jackson, D | 1 |
Sebree, T | 1 |
1 trial available for sumatriptan and Erythremia
Article | Year |
---|---|
A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Chemistry, Pharmaceutical; Drug Delivery Sys | 2007 |